Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3730298
Max Phase: Preclinical
Molecular Formula: C23H24Cl2FN3O2
Molecular Weight: 464.37
Molecule Type: Small molecule
Associated Items:
ID: ALA3730298
Max Phase: Preclinical
Molecular Formula: C23H24Cl2FN3O2
Molecular Weight: 464.37
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ncc(Cl)cc1C(=O)N[C@H]1CC[C@H](CN2C(=O)C(C)(F)c3ccc(Cl)cc32)CC1
Standard InChI: InChI=1S/C23H24Cl2FN3O2/c1-13-18(9-16(25)11-27-13)21(30)28-17-6-3-14(4-7-17)12-29-20-10-15(24)5-8-19(20)23(2,26)22(29)31/h5,8-11,14,17H,3-4,6-7,12H2,1-2H3,(H,28,30)/t14-,17-,23?
Standard InChI Key: ZEGBRYNTIJDVHP-UDTBGMHVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 464.37 | Molecular Weight (Monoisotopic): 463.1230 | AlogP: 5.22 | #Rotatable Bonds: 4 |
Polar Surface Area: 62.30 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.97 | CX Basic pKa: 2.68 | CX LogP: 3.96 | CX LogD: 3.96 |
Aromatic Rings: 2 | Heavy Atoms: 31 | QED Weighted: 0.68 | Np Likeness Score: -1.14 |
1. (2011) Cyclohexyl amide derivatives as CRF receptor antagonists, |
Source(1):